UBS Group AG - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is 19516R107. A total of 7 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q1 2021$16,000
+700.0%
1,178
+331.5%
0.00%
Q3 2020$2,000
-71.4%
273
-60.7%
0.00%
Q2 2020$7,000
-66.7%
695
-86.9%
0.00%
Q3 2019$21,000
+162.5%
5,304
+197.5%
0.00%
Q2 2019$8,0001,7830.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q4 2020
NameSharesValueWeighting ↓
INVESTMENT MANAGEMENT OF VIRGINIA LLC 285,132$3,071,0000.67%
MEITAV INVESTMENT HOUSE LTD 547,730$5,899,0000.23%
VILLERE ST DENIS J & CO LLC 87,850$946,0000.06%
BENJAMIN F. EDWARDS & COMPANY, INC. 14,520$156,0000.01%
Parallel Advisors, LLC 3,188$34,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 11,937$126,0000.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders